Triple-negative breast cancer (TNBC) is a distinct subtype of breast cancer characterized by the absence of estrogen receptors (Ers), progesterone receptors (PRs), and human epidermal growth factor receptor 2 (HER2/neu) cell surface proteins. Here, ERBB2 is linked to triple-negative breast carcinoma.